Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
A weight loss drug developer's stock soars
A weight loss drug developer's stock soars after a $198 million IPO
Shares of BioAge Labs (BIOA), a biopharmaceutical company focused on obesity drugs, opened 25% above its initial public offering (IPO) price on Thursday.
Competition explodes amid weight loss drug shortage
Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established drugmakers and an emerging market of compounded versions as telehealth companies look to tap into the fast-growing industry.
Weight-loss drug developer BioAge Labs aims to raise $198M from U.S. IPO
Weight-loss drug developer BioAge Labs (BIOA) on Wednesday announced the pricing of its upsized initial public offering of 11,000,000 shares of its common stock at a public offering price of $18.00 per share.
7h
on MSN
Prediction: Eli Lilly Will Dominate the Billion-Dollar Weight Loss Drug Market for This Key Reason
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
tyla
5h
James Corden explains why Ozempic 'didn’t work' for him after opening up on weight loss journey
Television presenter James Corden has this week admitted to having used Ozempic as a means of losing weight, but insisted ...
2d
on MSN
Depth of weight loss drug pipeline will support growth even as cost lowers, says StemPoint's Ross
Michelle Ross, StemPoint Capital CIO and Novo Nordisk shareholder, joins CNBC's 'Closing Bell' to discuss the criticism Novo ...
2d
US Senator Sanders says middlemen won't punish Novo if it cuts weight-loss drug prices
U.S. Senator Bernie Sanders said on Tuesday he had commitments from the nation's top pharmacy benefit managers that they ...
Axios
2d
Ozempic maker's CEO blames insurance companies for weight-loss drug prices
The chief executive of the company behind Ozempic and Wegovy blamed insurers and middlemen for the high costs of weight-loss ...
3d
Ozempic maker to testify before Senate committee on weight loss drug prices
Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on ...
NBC New York
16d
Novo Nordisk weight-loss drug is effective for kids as young as 6, study shows
A
drug
approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with ...
1h
At 46, James Corden Gets Candid About Weight Loss and Trying Ozempic
James Corden’s weight loss journey began in 2021. Now, he’s opening up about his experience with Ozempic and why it “didn’t ...
6h
on MSN
She took Ozempic, now she can't eat without vomiting. Lawsuit claims the drug made her ill
Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ozempic
Novo Nordisk
Wegovy
United States
Bernie Sanders
Feedback